Tandlæge Thomas Jørgensen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.6% 6.1% 6.0% 5.6% 12.2%  
Credit score (0-100)  35 40 40 42 19  
Credit rating  BB BBB BBB BBB BB  
Credit limit (kDKK)  -0.0 0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9

Net sales  0 0 0 0 0  
Gross profit  1,066 1,409 1,755 1,703 1,169  
EBITDA  -181 140 -89.8 175 744  
EBIT  -270 43.1 -189 78.6 744  
Pre-tax profit (PTP)  -392.2 -62.0 -286.2 -29.1 707.2  
Net earnings  -309.7 -48.4 -382.3 136.4 541.7  
Pre-tax profit without non-rec. items  -392 -62.0 -286 -29.1 707  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9

Tangible assets total  302 255 283 267 0.0  
Shareholders equity total  -260 -308 -690 -554 -12.3  
Interest-bearing liabilities  1,557 1,698 1,863 1,814 0.0  
Balance sheet total (assets)  1,671 1,615 1,491 1,525 96.0  

Net Debt  1,461 1,659 1,848 1,811 -65.0  
 
See the entire balance sheet

Volume 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,066 1,409 1,755 1,703 1,169  
Gross profit growth  0.0% 32.2% 24.5% -2.9% -31.3%  
Employees  0 0 3 2 2  
Employee growth %  0.0% 0.0% 0.0% -33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,671 1,615 1,491 1,525 96  
Balance sheet change%  0.0% -3.4% -7.7% 2.3% -93.7%  
Added value  -181.0 139.8 -89.8 178.1 743.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  1,165 -193 -122 -162 -1,068  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 1.0 2.0  

Profitability 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -25.3% 3.1% -10.8% 4.6% 63.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -14.0% 2.3% -9.0% 3.7% 68.2%  
ROI %  -17.3% 2.8% -10.4% 4.3% 82.0%  
ROE %  -18.5% -2.9% -24.6% 9.0% 66.8%  

Solidity 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9
Equity ratio %  -13.6% -16.1% -31.8% -26.7% -11.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -807.0% 1,186.5% -2,059.0% 1,037.7% -8.7%  
Gearing %  -599.6% -551.1% -269.8% -327.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  15.7% 6.6% 5.6% 5.9% 4.3%  

Liquidity 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9
Quick Ratio  0.3 0.3 0.2 0.3 0.9  
Current Ratio  0.4 0.4 0.2 0.3 0.9  
Cash and cash equivalent  96.1 39.2 14.6 2.7 65.0  

Capital use efficiency 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -554.9 -627.8 -1,115.3 -1,028.0 -12.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2016/9
2017
2017/9
2018
2018/9
2019
2019/9
2020
2020/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -30 89 372  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -30 87 372  
EBIT / employee  0 0 -63 39 372  
Net earnings / employee  0 0 -127 68 271